Recognition <<  1  2  3  4  5  6  7  8  >>
ISB SCIENTIST RECOGNIZED FOR AIDS VACCINE RESEARCH CONTRIBUTIONS
     ISB Research Scientist Daniel Zak, PhD, has been recognized by the Collaboration for AIDS Vaccine Discovery (CAVD) as a young/early-career investigator who has made important scientific contributions to the organization's work.
     Funded by the Bill & Melinda Gates Foundation, CAVD selects one or two early-career scientists from among approximately 450 researchers currently working to develop an AIDS vaccine.
      Zak has worked for three years in the lab of Alan Aderem, PhD, ISB co-founder and director, as part of the CAVD team led by Dr. M. Juliana McElrath at the Fred Hutchinson Cancer Research Center. The team seeks to understand how innate immune system activation controls vaccine-induced immunity.
Using systems biology approaches, Zak is working to identify markers of enhanced innate immune response. These markers can then be used to identify genes and pathways to be targeted in the next generation of AIDS vaccines.
      The CAVD provides recognition to early-career
scientists because development of an HIV vaccine is one of the most complicated biomedical challenges facing the world. Today's young investigators are needed to ensure that the field remains innovative and scientifically robust to meet the challenge of ending the HIV/AIDS epidemic. Dan Zak, PhD
    Recognized for excellence as an early-career scientific investigator
ISB ANNOUNCES NEARLY $30 MILLION IN GRANT AWARDS
 
Mark Gilchrist, National Institutes of Health (NIH), Epigenetic control of asthmatic inflammation by ATF 3
     Lee Pang, NIH, Multiscale kinetic analysis of Cu/Zn efflux in Halobacterium sp. NRC-1
     Lee Hood, Department of Defense (DoD), Blood biomarkers for assessing the exposure and responses of mammals to chemical and biological agents
     Lee Hood, DoD/TATRAC, Brain-region and cell-type specific transcripts for informative diagnostics
     Dan Martin, Washington Life Sciences Discovery Fund, High-throughput generation of monoclonal anti-peptide antibodies for high sensitivity targeted MS analysis of biomarker candidates
     John Boyle/Eric Deutch, NIH, Providing Peptide Atlas based services through the caGRID infrastructure
     Qiang Tian, NIH, Comprehensive identification of bivalent promoters in brain tumor stem cells Qiang Tian, DoD,
 
  Automated biological sample concentration and detection system
     Nat Goodman, Accelerate Brain Cancer Cure Foundation, Initial ISB support for ABC2 research program (Accelerate Brain Cancer Cure, Inc.)
     Lee Hood, DoD, Discovery and validation of peripheral biomarkers of traumatic brain injury
     Alan Aderem, NIH, Transcriptional control in the macrophage response to pathogens (RCE/Miller)
     Lee Hood, NIH, LTQ-Orbitrap XL for protein identification and biomarkers
     Monica Orellana, National Science Foundation (NSF), Collaborative research: A systems biology approach of diatom response to ocean
  acidification and climate change
     Robert Moritz/Lee Hood, NIH, Complete Human Peptide- and MRM-Atlas (ARRA)
     Lee Hood/Robert Moritz, NSF, MRI: Development of ion-mobility enhanced electron-transfer dissociation for elucidating biological networks using a systems biology approach
     Center for Inquiry Science, State of Washington, Everett Science Partnership: Observing and improving student learning
     Ilya Shmulevich, NIH, Center for Systems Analysis of the Cancer Regulome
     (Note: List includes primary investigator, funding organization and subject of the grant.)

PAGE 7 <<  1  2  3  4  5  6  7  8  >>